Drugs / nitroprussiate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04685941 | Jan 2021 → Oct 2022 | coronary microvascular disorder, myocardial infarction | Fundación EPIC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nitroprussiate | “Intracoronary bolus of at least 200 mcg of nitroprussiate or 500 mcg of intracoronary adenosine during 2 minutes.” NCT04685941 ↗ |
| Route | Other | “Intracoronary bolus of at least 200 mcg of nitroprussiate” NCT04685941 ↗ |